Embla Medical hf (Embla Medical hf) Cash-to-Debt : 0.14 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Embla Medical hf Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Embla Medical hf's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.14.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Embla Medical hf couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Embla Medical hf's Cash-to-Debt or its related term are showing as below:

OSSUY' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.1 Med: 0.19 Max: 0.31
Current: 0.14

During the past 13 years, Embla Medical hf's highest Cash to Debt Ratio was 0.31. The lowest was 0.10. And the median was 0.19.

OSSUY's Cash-to-Debt is ranked worse than
90.24% of 861 companies
in the Medical Devices & Instruments industry
Industry Median: 1.91 vs OSSUY: 0.14

Embla Medical hf Cash-to-Debt Historical Data

The historical data trend for Embla Medical hf's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Embla Medical hf Cash-to-Debt Chart

Embla Medical hf Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.16

0.21

0.19

0.16

Embla Medical hf Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															0.15	0.15	0.15	0.16	0.14

Competitive Comparison of Embla Medical hf's Cash-to-Debt

For the Medical Devices subindustry, Embla Medical hf's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Embla Medical hf's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cash-to-Debt falls into.

Embla Medical hf Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Embla Medical hf's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	72.653	/	(43.325	+	424.407)
	=	0.16

Embla Medical hf's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	77.358	/	(84.175	+	475.58)
	=	0.14

Embla Medical hf (OTCPK:OSSUY) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Embla Medical hf Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf (Embla Medical hf) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSUY) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSR:Denmark

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.